Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 15/20 | 0.49 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.49 |
| ▸ | CTSD | P07339 | 6/20 | 0.47 |
| ▸ | BCHE | P06276 | 5/20 | 0.47 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8729411 | 0.89 | BACE1 (0.61) | BACE1SLC6A11CTSDBCHE | |
| SCHEMBL8734453 | 0.89 | BACE1 (0.47) | BACE1SLC6A11CTSDBCHEBACE2 | |
| SCHEMBL7390488 | 0.89 | BACE1 (0.47) | BACE1SLC6A11CTSDBCHEBACE2 | |
| SCHEMBL8729433 | 0.87 | BCHE (0.43) | BACE1SLC6A11CTSDBCHEBACE2 | |
| SCHEMBL7322817 | 0.87 | BACE1 (0.50) | BACE1SLC6A11CTSDBCHE | |
| SCHEMBL8731465 | 0.87 | BACE1 (0.50) | BACE1SLC6A11CTSDBCHE | |
| SCHEMBL8734448 | 0.85 | BCHE (0.65) | BACE1SLC6A11CTSDBCHE | |
| SCHEMBL3348155 | 0.82 | BACE1 (0.54) | BACE1SLC6A11CTSDBCHEBACE2 | |
| SCHEMBL3348148 | 0.82 | BACE1 (0.54) | BACE1SLC6A11CTSDBCHEBACE2 | |
| SCHEMBL8734182 | 0.81 | BCHE (0.56) | BACE1SLC6A11CTSDBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5708004-A | ENZYME INHIBITORS FOR TREATMENT OF AIDS | MONSANTO COMPANY (US) | 1998-01-13 | — | — | US | disclosed |
| US-5703076-A | TREATING HIV, AIDS | G. D. SEARLE & CO. (US) | 1997-12-30 | — | — | US | disclosed |
| US-5698569-A | Retroviral protease inhibitors | G. D. SEARLE & CO. (US) | 1997-12-16 | — | — | US | disclosed |
| US-5510349-A | HUMAN IMMUNODEFICIENCY VIRUS | G.D. SEARLE & CO. (US) | 1996-04-23 | — | — | US | disclosed |
| US-5510487-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS | G.D. SEARLE & CO. (US) | 1996-04-23 | — | — | US | disclosed |
| US-5510378-A | Retroviral protease inhibitors | G.D. SEARLE & CO. (US) | 1996-04-23 | — | — | US | disclosed |